Shots:
Sapient’s new partnership with Alamar Biosciences supercharges its multi-omics engine, bringing the ultra-sensitive NULISA™ platform in-house to capture hard-to-measure cytokines and chemokines, unlocking deeper biological insights beyond the reach of mass spectrometry alone
The collaboration with Rancho Biosciences is redefining large-scale data intelligence, enabling Sapient’s DynamiQ™ platform to seamlessly integrate, structure, and analyze massive multi-omics and real-world…
The MedTech industry is at the forefront of technological innovation, constantly evolving to improve patient care and streamline healthcare processes. With rapid advancements and changing regulations, staying ahead of trends is crucial for success. This exploration highlights how advancements in technology and strategic market insights drive this dynamic sector.
The global MedTech landscape is a…
Shots:
Abuse-deterrent products are prescription medications, primarily opioids and certain stimulants, designed to resist common methods of misuse, such as crushing, snorting, or injecting
Protega Pharmaceuticals’ RoxyBond is the first and only FDA-approved, immediate-release abuse-deterrent opioid indicated for managing severe pain when alternative treatments are inadequate
PharmaShots is pleased to feature Paul Howe, Chief Operations…
The rise of collagen supplements in wellness and beauty sectors underscores the importance of selecting the right collagen manufacturer. As consumers demand effective and trustworthy products, the choice of a manufacturer becomes a pivotal factor in brand success and consumer trust. This article delves into why choosing the right collagen manufacturer is essential for building…
A B2B event designed to connect Drug Discovery Experts, Biotech Innovation, and emerging technologies. This expert-led, two-day event blends keynotes, case studies, panel discussions, and 1:1 meetings to turn research into real-world impact.
For any queries, reach out to Tina Aston at ta@worldbigroup.com
Related Post: Clinical Trials Operations DACH 2025 | Sep 18 | Basel,…
The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2025 takes place in Vösendorf, Austria on 24-25 November. The 5th anniversary edition of AUTOMA+ gathers leading innovators and IT professionals to discuss the directions of the advanced industry shift and celebrate this milestone together.
The 2-day agenda includes topics:
Ethical and human-centric AI;
Smart manufacturing techniques (digital…
Aesthetic and beauty industry, underplayed by cosmeceuticals, shapes a soaring market worth $312.33B. Cosmeceuticals are known for their medical benefits beyond cosmetics and typically come in the forms of topical creams, serums, and lotions
Let’s unearth the secrets of cosmeceuticals like never before through engaging articles, illustrative infographics, regulatory updates, and much more
The…
Discovery & Development Summit Asia 2025 is Global Engage’s inaugural platform that brings together the Drug Discovery & Development, Nucleic Acid Therapeutics and Precision Medicine congresses. This summit allows the exploration of the full spectrum of therapeutic innovation, from early-stage discovery to clinical translation and commercialization. Attendees will gain insights into assay development, screening technologies,…
Shots:
The integration of innovative technologies in healthcare, such as digital health platforms and AI-enabled applications, is transforming the way diseases are detected, diagnosed, treated, and prevented
The global Digital Health market is expected to reach $197.88B in 2025 and grow at a CAGR of 6.88%, reaching $258.25B by 2029
PharmaShots presents a concise report…
Innovative technologies are reshaping orthodontic care, providing solutions that improve patient experiences and treatment outcomes. From 3D imaging to digital impressions, these advancements are setting new standards in dental care, promising greater accuracy, comfort, and efficiency.
The evolution of orthodontic care has been remarkable, with technology playing a crucial role in enhancing patient experiences. Over…

